The transaction is expected to be immediately accretive.
Probiotica currently markets a full line of OTC sports nutrition products and other food supplements, with a 30% share of the market.
Valeant chairman and CEO Michael Pearson said they believe that they have a unique opportunity not only in Brazil, but in potential export markets as well.
"Probiotica’s strong reputation in Brazil makes it a perfect fit into our growing consumer portfolio," Pearson added.